F Baert

Once daily MMX mesalazine for the treatment of mild‐to‐moderate ulcerative colitis: a phase II, dose‐ranging study

Geert D’Haens, Daan W. Hommes, L.G.J.B. Engels et al. · Alimentary Pharmacology & Therapeutics · 2006 · 82 citations · Full text

A combined regimen of infliximab and azathioprine induces better endoscopic healing than classic step-up therapy in newly diagnosed Crohn's disease

G. D’Haens, Daan W. Hommes, F Baert et al. · Ghent University Academic Bibliography (Ghent University) · 2006 · 27 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +9

Drug-concentration versus symptom-driven dose adaptation of Infliximab in patients with active Crohn's disease: a prospective, randomised, multicentre trial (Tailorix)

G. D’Haens, Séverine Vermeire, Guy Lambrecht et al. · 2016 · 25 citations

Drug-concentration Versus, Anti-inflammatory, Pharmacology +8

Nitroimidazol antibiotics are efficacious for prophylaxis of postoperative recurrence of Crohn's disease: a placebo controlled trial

Paul Rutgeerts, Geert D’Haens, F Baert et al. · Gastroenterology · 1999 · 14 citations

Nitroimidazol Antibiotics, Antibiotics, Gastroenterology +7